Latest stories on JANX
Janux Therapeutics: It's Too Early To Tell If Prostate Cancer Program Can Succeed
Seeking Alpha42 · neutralgeneral
Janux Therapeutics, Inc. (JANX) Presents at 12th Annual Cantor Fitzgerald Global Healthcare Conference - Slideshow
Seeking Alpha55 · neutralproduct/pr
Janux Therapeutics Announces First Patient Dosed in Phase 1 Study of JANX013
StockTitan63 · neutralproduct/pr
Janux Therapeutics upgraded to Outperform from Peer Perform at Wolfe Research
The Fly61 · neutralanalyst
Janux Therapeutics Price Target Lowered To 35 From 38 At Stifel
The Fly34 · bearishanalyst
Janux Therapeutics Price Target Lowered To 55 From 58 At Guggenheim
The Fly37 · neutralanalyst
Janux Therapeutics GAAP EPS of -$0.35 misses by $0.09, revenue of $10.27M misses by $7.67M
Seeking Alpha34 · bearishearnings
Janux Therapeutics Reports Q2 Eps 35c Consensus 29c
The Fly68 · bullishearnings
Janux Therapeutics, Inc. (JANX) files 8-K
SEC 8-K50 · neutralgeneral
Janux Therapeutics Reports Second Quarter 2026 Financial Results and Business Highlights
StockTitan55 · neutralearnings
Is Janux Therapeutics, Inc. (JANX) Stock a Biotech Opportunity With Next-Generation Immunotherapy Potential?
Yahoo Top56 · neutralanalyst
Janux Therapeutics Announces Departure of Chief Medical Officer
TipRanks34 · bearishgeneral
Janux Therapeutics, Inc. (JANX) files 8-K
SEC 8-K50 · neutralgeneral
Janux Therapeutics, Inc. (JANX) files 8-K
SEC 8-K50 · neutralgeneral